What is IAM's market cap?

$1.13B, based on the Oct 16 close of $23.81.

NASDAQ · IAM

Iambic Therapeutics, Inc. Common Stock (IAM)

$23.81+25.91%

Close Oct 16, 2026 · split-adjusted

Oct 16, 2026$23.81▲ 25.91% in range

Oct 15, 2026Low $18.91 · High $23.81Oct 16, 2026

What changed · written from our data

As of Oct 16, 2026

Iambic Therapeutics closed at $23.81 on Oct 16, up 25.91% — matching its highest close since Oct 15.

Short interest was 8.0K shares at the Nov 15 settlement, up 311.1% from the prior report (1.0 days to cover).

Market cap$1.13B47.4M shares

Revenue · quarter——

Diluted EPS——

P/E · TTM—

Net margin—

Dividend yieldNone

Range since Oct 1518.91 – 23.810.0% from high

Volume3.0M

Volatility · 60d—Annualised

Short % of float—1.0 days to cover

Net cash—

Next earnings—Not scheduled

Split-adjusted performance

1W —1M —3M —6M —YTD —1Y —3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Short interest

Details →

Shares short8.0K+311.1% vs prior

Days to cover1.0Settled Nov 15

% of float—

Short vol. 10d55.8%of daily volume

News about Iambic Therapeutics

All news →

No recent articles focused on Iambic Therapeutics.

Quick answers

What does Iambic Therapeutics do?: Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.
What is IAM's market cap?: $1.13B, based on the Oct 16 close of $23.81.

About Iambic Therapeutics

Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.

Listed Oct 15, 2026iambic.ai

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology